Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by Erasca, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216788
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development | $27,265 | $25,969 |
| In-process research and development | 150,000 | — |
| General and administrative | 10,646 | 9,661 |
| Total operating expenses | 187,911 | 35,630 |
| Loss from operations | (187,911) | (35,630) |
| Other income (expense) | ||
| Interest income | 4,449 | 4,740 |
Item 1. Financial Statements.
FAQ
- What is Erasca, Inc.'s R&D?
- Erasca, Inc. (ERAS) reported R&D of $27.27M in Q1 2026.
- How has Erasca, Inc.'s R&D changed year-over-year?
- Erasca, Inc.'s R&D increased by 5.0% year-over-year, from $25.97M to $27.27M.
- What is the long-term trend for Erasca, Inc.'s R&D?
- Over 4 years (2021 to 2025), Erasca, Inc.'s R&D has grown at a 5.9% compound annual growth rate (CAGR), from $73.92M to $92.85M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Erasca, Inc.'s r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude